Copyright Reports & Markets. All rights reserved.

Global Oxaliplatin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Oxaliplatin Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Mannitol
      • 1.2.2 Glucose Solution
      • 1.2.3 Lactose Solution
      • 1.2.4 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Colorectal Cancer
      • 1.3.2 Stomach Cancer
      • 1.3.3 Ovarian Cancer
      • 1.3.4 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Sanofi-Aventis
      • 2.1.1 Business Overview
      • 2.1.2 Oxaliplatin Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Sanofi-Aventis Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Yakult honsha
      • 2.2.1 Business Overview
      • 2.2.2 Oxaliplatin Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Yakult honsha Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Dr Reddy's laboratories
      • 2.3.1 Business Overview
      • 2.3.2 Oxaliplatin Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Dr Reddy's laboratories Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Sun Pharmaceutical
      • 2.4.1 Business Overview
      • 2.4.2 Oxaliplatin Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Sun Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Teva
      • 2.5.1 Business Overview
      • 2.5.2 Oxaliplatin Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Teva Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Fresenius Kabi
      • 2.6.1 Business Overview
      • 2.6.2 Oxaliplatin Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Fresenius Kabi Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Hospira
      • 2.7.1 Business Overview
      • 2.7.2 Oxaliplatin Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Hospira Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Mylan
      • 2.8.1 Business Overview
      • 2.8.2 Oxaliplatin Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Mylan Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Jiangsu Hengrui Medicine
      • 2.9.1 Business Overview
      • 2.9.2 Oxaliplatin Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Jiangsu Hengrui Medicine Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Nanjing Pharmaceutical Factory
      • 2.10.1 Business Overview
      • 2.10.2 Oxaliplatin Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Jiangsu Aosaikang Pharmaceutical
      • 2.11.1 Business Overview
      • 2.11.2 Oxaliplatin Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Qilu Pharmaceutical
      • 2.12.1 Business Overview
      • 2.12.2 Oxaliplatin Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Qilu Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Hisun Pharmaceutical
      • 2.13.1 Business Overview
      • 2.13.2 Oxaliplatin Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Hisun Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Lunan Pharmaceutical
      • 2.14.1 Business Overview
      • 2.14.2 Oxaliplatin Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Lunan Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Luoxin
      • 2.15.1 Business Overview
      • 2.15.2 Oxaliplatin Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Luoxin Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Halfsky Pharmacy
      • 2.16.1 Business Overview
      • 2.16.2 Oxaliplatin Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Halfsky Pharmacy Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 YRPG
      • 2.17.1 Business Overview
      • 2.17.2 Oxaliplatin Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 YRPG Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Hainan Jinrui Pharmaceutical
      • 2.18.1 Business Overview
      • 2.18.2 Oxaliplatin Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Jari Pharmaceutical
      • 2.19.1 Business Overview
      • 2.19.2 Oxaliplatin Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Jari Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 Chiatai Tianqing
      • 2.20.1 Business Overview
      • 2.20.2 Oxaliplatin Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 Chiatai Tianqing Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Oxaliplatin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Oxaliplatin Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Oxaliplatin Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Oxaliplatin Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Oxaliplatin Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Oxaliplatin Market Analysis by Regions

    • 4.1 Global Oxaliplatin Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Oxaliplatin Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Oxaliplatin Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Oxaliplatin Sales and Growth Rate (2014-2019)
    • 4.3 Europe Oxaliplatin Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Oxaliplatin Sales and Growth Rate (2014-2019)
    • 4.5 South America Oxaliplatin Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Oxaliplatin Sales and Growth Rate (2014-2019)

    5 North America Oxaliplatin by Country

    • 5.1 North America Oxaliplatin Sales, Revenue and Market Share by Country
      • 5.1.1 North America Oxaliplatin Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Oxaliplatin Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Oxaliplatin Sales and Growth Rate (2014-2019)
    • 5.3 Canada Oxaliplatin Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Oxaliplatin Sales and Growth Rate (2014-2019)

    6 Europe Oxaliplatin by Country

    • 6.1 Europe Oxaliplatin Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Oxaliplatin Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Oxaliplatin Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Oxaliplatin Sales and Growth Rate (2014-2019)
    • 6.3 UK Oxaliplatin Sales and Growth Rate (2014-2019)
    • 6.4 France Oxaliplatin Sales and Growth Rate (2014-2019)
    • 6.5 Russia Oxaliplatin Sales and Growth Rate (2014-2019)
    • 6.6 Italy Oxaliplatin Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Oxaliplatin by Country

    • 7.1 Asia-Pacific Oxaliplatin Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Oxaliplatin Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Oxaliplatin Revenue and Market Share by Country (2014-2019)
    • 7.2 China Oxaliplatin Sales and Growth Rate (2014-2019)
    • 7.3 Japan Oxaliplatin Sales and Growth Rate (2014-2019)
    • 7.4 Korea Oxaliplatin Sales and Growth Rate (2014-2019)
    • 7.5 India Oxaliplatin Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Oxaliplatin Sales and Growth Rate (2014-2019)

    8 South America Oxaliplatin by Country

    • 8.1 South America Oxaliplatin Sales, Revenue and Market Share by Country
      • 8.1.1 South America Oxaliplatin Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Oxaliplatin Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Oxaliplatin Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Oxaliplatin Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Oxaliplatin Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Oxaliplatin by Countries

    • 9.1 Middle East and Africa Oxaliplatin Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Oxaliplatin Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Oxaliplatin Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Oxaliplatin Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Oxaliplatin Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Oxaliplatin Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Oxaliplatin Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Oxaliplatin Sales and Growth Rate (2014-2019)

    10 Global Oxaliplatin Market Segment by Type

    • 10.1 Global Oxaliplatin Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Oxaliplatin Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Oxaliplatin Revenue and Market Share by Type (2014-2019)
    • 10.2 Mannitol Sales Growth and Price
      • 10.2.1 Global Mannitol Sales Growth (2014-2019)
      • 10.2.2 Global Mannitol Price (2014-2019)
    • 10.3 Glucose Solution Sales Growth and Price
      • 10.3.1 Global Glucose Solution Sales Growth (2014-2019)
      • 10.3.2 Global Glucose Solution Price (2014-2019)
    • 10.4 Lactose Solution Sales Growth and Price
      • 10.4.1 Global Lactose Solution Sales Growth (2014-2019)
      • 10.4.2 Global Lactose Solution Price (2014-2019)
    • 10.5 Other Sales Growth and Price
      • 10.5.1 Global Other Sales Growth (2014-2019)
      • 10.5.2 Global Other Price (2014-2019)

    11 Global Oxaliplatin Market Segment by Application

    • 11.1 Global Oxaliplatin Sales Market Share by Application (2014-2019)
    • 11.2 Colorectal Cancer Sales Growth (2014-2019)
    • 11.3 Stomach Cancer Sales Growth (2014-2019)
    • 11.4 Ovarian Cancer Sales Growth (2014-2019)
    • 11.5 Other Sales Growth (2014-2019)

    12 Oxaliplatin Market Forecast (2019-2024)

    • 12.1 Global Oxaliplatin Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Oxaliplatin Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Oxaliplatin Market Forecast (2019-2024)
      • 12.2.2 Europe Oxaliplatin Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Oxaliplatin Market Forecast (2019-2024)
      • 12.2.4 South America Oxaliplatin Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Oxaliplatin Market Forecast (2019-2024)
    • 12.3 Oxaliplatin Market Forecast by Type (2019-2024)
      • 12.3.1 Global Oxaliplatin Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Oxaliplatin Market Share Forecast by Type (2019-2024)
    • 12.4 Oxaliplatin Market Forecast by Application (2019-2024)
      • 12.4.1 Global Oxaliplatin Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Oxaliplatin Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

      In this report, only the finished drug is covered, exclude API.

      Scope of the Report:
      The Oxaliplatin concentration is high; there are many manufacturers in the world, and high-end products mainly from USA and Europe. In the world wide, giant manufactures mainly distribute in US, Europe and China such as Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Teva and Jiangsu Hengrui Medicine.
      The technological level of Oxaliplatin in China has a big gap compared with the international advanced level. Outstanding performance in product application performance is not outstanding, function is not strong, supporting enough, clean low level, product updates slow, long development cycle. There is little Oxaliplatin performance in China at or near the international advanced level.
      The worldwide market for Oxaliplatin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Oxaliplatin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Sanofi-Aventis
      Yakult honsha
      Dr Reddy's laboratories
      Sun Pharmaceutical
      Teva
      Fresenius Kabi
      Hospira
      Mylan
      Jiangsu Hengrui Medicine
      Nanjing Pharmaceutical Factory
      Jiangsu Aosaikang Pharmaceutical
      Qilu Pharmaceutical
      Hisun Pharmaceutical
      Lunan Pharmaceutical
      Luoxin
      Halfsky Pharmacy
      YRPG
      Hainan Jinrui Pharmaceutical
      Jari Pharmaceutical
      Chiatai Tianqing

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Mannitol
      Glucose Solution
      Lactose Solution
      Other

      Market Segment by Applications, can be divided into
      Colorectal Cancer
      Stomach Cancer
      Ovarian Cancer
      Other

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Oxaliplatin product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Oxaliplatin, with price, sales, revenue and global market share of Oxaliplatin in 2017 and 2018.
      Chapter 3, the Oxaliplatin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Oxaliplatin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Oxaliplatin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Oxaliplatin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now